Australia Biotech Invest & Partnering, held on Thursday 29 October, remains the preeminent opportunity for companies to present their technology and story to a network of potential partners and investors.
Despite the volatility and challenging market brought upon by the pandemic, Australia’s biotechnology industry presents a compelling opportunity for investors and international partners.
Australia Biotech Invest & Partnering 2020, AusBiotech’s leading one-day investment conference focused on trends in life sciences investment, will provide up to 30 private and publicly funded companies an opportunity to take centre stage, presenting to an audience of investors to make meaningful connections. Invest 2020, will also feature keynote sessions from investment leaders on industry trends and market updates and provide access to AusPartnering for scheduling virtual one-on-one meetings.
Investors will have access to company presentations for a further 30 days post the event. Investor attendees represent venture capital, private equity, HNW individuals, research analysts and brokers, as well as industry executives from major global pharmaceutical companies.